It was found that DACH1 expression was generally reduced in esophageal cancer tissues, and this alteration was due to the regulation of methylation in the promoter region of the gene, while DACH1 expression was upregulated after treating some esophageal cancer cell lines with methylation enzyme inhibitors in vitro [16]. The gene discussed is DACH1; the disease is esophageal cancer.